315 related articles for article (PubMed ID: 28561682)
21. Radiation therapy of cutaneous cancers.
Hennequin C; Rio E; Quéro L; Clavère P
Cancer Radiother; 2022; 26(1-2):397-403. PubMed ID: 34955421
[TBL] [Abstract][Full Text] [Related]
22. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer.
Silk AW; Barker CA; Bhatia S; Bollin KB; Chandra S; Eroglu Z; Gastman BR; Kendra KL; Kluger H; Lipson EJ; Madden K; Miller DM; Nghiem P; Pavlick AC; Puzanov I; Rabinowits G; Ruiz ES; Sondak VK; Tavss EA; Tetzlaff MT; Brownell I
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35902131
[TBL] [Abstract][Full Text] [Related]
23. Preferentially expressed antigen in melanoma expression in nonmelanoma skin cancers and melanocytes in surrounding skin.
Elsensohn A; Hanson J; Ferringer T
J Cutan Pathol; 2021 Sep; 48(9):1150-1155. PubMed ID: 33719089
[TBL] [Abstract][Full Text] [Related]
24. Systemic therapy of skin carcinoma.
Kempf RA
Cancer Treat Res; 1995; 78():137-62. PubMed ID: 8595141
[No Abstract] [Full Text] [Related]
25. Clinical and dermoscopic features of combined cutaneous squamous cell carcinoma (SCC)/neuroendocrine [Merkel cell] carcinoma (MCC).
Suárez AL; Louis P; Kitts J; Busam K; Myskowski PL; Wong RJ; Chen CS; Spencer P; Lacouture M; Pulitzer MP
J Am Acad Dermatol; 2015 Dec; 73(6):968-75. PubMed ID: 26433246
[TBL] [Abstract][Full Text] [Related]
26. Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases.
Knackstedt R; Sussman TA; McCahon L; Song JM; Funchain P; Gastman B
Ann Oncol; 2019 Aug; 30(8):1399-1400. PubMed ID: 31250007
[No Abstract] [Full Text] [Related]
27. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
O'Reilly Zwald F; Brown M
J Am Acad Dermatol; 2011 Aug; 65(2):253-261. PubMed ID: 21763561
[TBL] [Abstract][Full Text] [Related]
28. Pembrolizumab and other immune checkpoint inhibitors in locally advanced or metastatic Merkel Cell Carcinoma: safety and efficacy.
Marchand A; Kervarrec T; Bhatia S; Samimi M
Expert Rev Anticancer Ther; 2020 Dec; 20(12):1093-1106. PubMed ID: 33044876
[TBL] [Abstract][Full Text] [Related]
29. Keratinocytic skin cancers-Update on the molecular biology.
Win TS; Tsao H
Cancer; 2023 Mar; 129(6):836-844. PubMed ID: 36645692
[TBL] [Abstract][Full Text] [Related]
30. [Place of radiotherapy in the treatment of cutaneous carcinomas].
Quéro L; Fumagalli I; Benadon B; Mignot F; Guillerm S; Labidi M; Hennequin C
Cancer Radiother; 2021 Oct; 25(6-7):593-597. PubMed ID: 34400089
[TBL] [Abstract][Full Text] [Related]
31. Where do we stand with immunotherapy for nonmelanoma skin cancers in the curative setting?
Alberti A; Gurizzan C; Baggi A; Bossi P
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):89-95. PubMed ID: 37997885
[TBL] [Abstract][Full Text] [Related]
32. The biology and treatment of Merkel cell carcinoma: current understanding and research priorities.
Harms PW; Harms KL; Moore PS; DeCaprio JA; Nghiem P; Wong MKK; Brownell I;
Nat Rev Clin Oncol; 2018 Dec; 15(12):763-776. PubMed ID: 30287935
[TBL] [Abstract][Full Text] [Related]
33. UV-induced skin cancer: similarities--variations.
Boukamp P
J Dtsch Dermatol Ges; 2005 Jul; 3(7):493-503. PubMed ID: 15967008
[TBL] [Abstract][Full Text] [Related]
34. Molecular biology of malignant melanoma and other cutaneous tumors.
Pons M; Quintanilla M
Clin Transl Oncol; 2006 Jul; 8(7):466-74. PubMed ID: 16870533
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
Roberts MR; Asgari MM; Toland AE
Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
[TBL] [Abstract][Full Text] [Related]
36. Update on Merkel Cell Carcinoma.
Harms PW
Clin Lab Med; 2017 Sep; 37(3):485-501. PubMed ID: 28802497
[TBL] [Abstract][Full Text] [Related]
37. Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan.
Fujisawa Y; Funakoshi T; Nakamura Y; Ishii M; Asai J; Shimauchi T; Fujii K; Fujimoto M; Katoh N; Ihn H
J Dermatol Sci; 2018 Dec; 92(3):230-236. PubMed ID: 30527378
[TBL] [Abstract][Full Text] [Related]
38. [Possible immunotherapies of skin cancers].
Lengyel LZS; Gyulai GYR
Magy Onkol; 2019 Sep; 63(3):239-245. PubMed ID: 31538441
[TBL] [Abstract][Full Text] [Related]
39. Melanoma and nonmelanoma skin cancer.
Curr Opin Oncol; 1991 Apr; 3(2):420-32. PubMed ID: 2070001
[No Abstract] [Full Text] [Related]
40. UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.
Liu-Smith F; Jia J; Zheng Y
Adv Exp Med Biol; 2017; 996():27-40. PubMed ID: 29124688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
